Image For Activity Cover
2019 HFSA ASM Core Learning Pathway
General Meeting Information
For those seeking core competencies and updates in heart failure care, this specific learning pathway features Maintenance of Certification credits and is designed with online summaries of key takeaways from “Ten Simple Tips” and “Clinical Conundrums” sessions at the 2019 HFSA ASM. These session provide up to 14.50 CME Credits/ MOC points.
Intended Audience

HFSA’s 2019 Core Learning Path is intended for physicians, nurses, nurse practitioners, pharmacists, scientists, and health care professionals who specialize or have an interest  in heart failure.

Co-Chairs & Planning Committee
Co-Chair(s)
Sheryl Chow PharmD, FHFSA
Dennis McNamara MD, MS
Sara Paul DNP, FNP, FHFSA
Wilson Tang, MD, FHFSA

Program Committee
Jeffrey Alexis, MD
Larry Allen, MD, MHS, FHFSA
Ponrathi R. Athilingam, PhD, ACNP, FAANP, FHFSA
Arvind Bhimaraj, MD, MPH, FHFSA
Javed Butler, MD, MPH, MBA
Horng Chen, MBBCh
Julie Creaser RN, MN
Anita Deswal, MD, MPH, FHFSA
Adam Devore, MD
Robert Didomenico, PharmD
Sandra Dunbar, RN, PhD
Omar Abou Ezzeddine, MD, CM, MS
Debra Ferguson, ANP-BC
Eiran Gorodeski, MD, MPH, FHFSA
Justin Grodin, MD, MPH
Doug Jennings, PharmD
Peggy Kirkwood, RN, MSN, ACNPC, CHFN, AACC
Liviu Klein, MD, MS
Peter Liu, MD
Alanna Morris, MD, MSc, FHFSA
Srinivas Murali, MD
J. Herbert Patterson, PharmD, FHFSA
Anu Lala Trindad, MD
Gurusher Panjrath, MBBS
Bunny Pozehl, RN, PhD
Julie Rosenthal, MD
Flora Sam, MD, FHFSA, FACC, FAHA
Doug Sawyer, MD, PhD
Kristen Sethares, PhD, RN, CNE, FAHA
Palak Shah, MD, MS, FHFSA
Marc Simon, MD
Amanda Vest, MBBS, MPH, FHFSA
Course Details & Faculty Listing
Ten Simple Tips: Strategies for Heart Failure Prevention (AHA Joint Session)
Moderator(s): Sheryl Chow; Michele Hamilton
Clinically Applicable Biomarkers for Early Detection of HF  Speaker: Alan Maisel
Trifecta of Lifestyle Modifications: Diet, Exercise, and Cardiac Rehab  Speaker: Ileana Pina
Risk Factor Moderation Using Pharmacologic Therapy  Speaker: Orly Vardeny
Model for Primary Care Providers and Telehealth  Speaker: Farruk Merchant
Ten Simple Tips for Managing Complexities of Cardiogenic Shock
Moderator(s): Maya Guglin; Michael Givertz
When to Pull the Trigger on Acute MCS  Speaker: Jorge Silva Enciso
Which Pump in What Scenario -- IABP vs Impella vs Tandem Heart?  Speaker: Arvind Bhimaraj
ECMO for Cardiogenic Shock  Speaker: Edward Soltesz
RV Support in Cardiiogenic Shock  Speaker: Arthur Garan
Pharmacologic Management in the Percutaneous Mechanical Circulatory Support Patient  Speaker: Rob Didomenico
Ten Simple Tips: Identifying the Ever-Elusive Volume Overload in the Clinic
Moderator(s): Tariq Ahmad; Sara Paul
Why Do HF Patients Experience Volume Overload?  Speaker: Tariq Ahmad
Assessing Congestion - Is There a Role for History and Physical Exam  Speaker: Jennifer Thibodeau
Serum Biomarkers to Diagnose and Treat Congestion  Speaker: James Januzzi
Ultrasound at the Bedside: Portable Ultrasound and Echocardiography to Evaluate for Congestion  Speaker: Amil Shah
Using Implantable Sensors and Impedanace to Assess and Optimize Volume Status  Speaker: Divya Gupta
Direct Blood Volume Measurement to Assess Congestion - Is It Necessary? Can We Afford It?  Speaker: Wayne Miller
Ten Simple Tips: Implementation of Technologies to Assist in HF Care and Reduce Readmissions (Joint Session ACC)
Moderator(s): J. Thomas Heywood; Gurusher Panjrath
Quality Metrics for HF Care: What Has the Life Span of a Housefly Taught Us?  Speaker: Marvin Konstam
Systems of Care Strategies to Enhance HF Care- pharmacists, Navigators, Paramedics and Beyond  Speaker: Mary Walsh
Queuing Theory to Redesign Access to HF Care Post Hospitalization  Speaker: Clyde Yancy
Using the Current Digital World to Optimize HF Care at Home: Apps to Apple Watches  Speaker: Ashish Atreja
Engineering Solutions for HF: Collaborations to Enhance Innovations in Care for HF as a Chronic Disease Speaker: Gerard Cote
Clinical Conundrums in Pharmacologic Therapy for HFrEF: Case-Based Approaches
Moderator(s): Jean Nappi; Kavita Sharma
Physician Panelist (Cases 1-3)  Panelist: Faiez Zannad
Nurse Panelist (Cases 1-3)  Panelist: Marie Galvao
Pharmacist Panelist (Cases 1-3)  Panelist: Kerry Pickworth
Physician Panelist (Cases 1-3)  Panelist: Kirkwood Adams
Pharmacist Panelist (Cases 1-3)  Panelist: Jo Ellen Rodgers
Nurse Panelist (Cases 1-3)  Panelist: Sara Paul
Ten Simple Tips: Cardiac Amyloidosis: No Longer an Academic Exercise, Now a Treatable Pandemic (ASNC Joint Session)
Moderator(s): James Udelson; Daniel Judge
Cardiac Amyloidosis: Road to Diagnosis and a Race Against Time  Speaker: Mazen Hanna 
Role of Imaging in Diagnosis: Has Endomyocardial Biopsy Become Obsolete?  Speaker: Omar F. Abou Ezzeddine
Cardiologists’ Amyloid Polyneuropathy Primer  Speaker: Sami Khella
2019 Update on Management of Transthyretin Amyloidosis  Speaker: Mathew Maurer
2019 Update on Management of Light Chain Amyloidosis  Speaker: Vaishali Sanchorawala
Advanced Therapies for Amyloidosis: No Longer an Absolute Contraindication for Some  Speaker: Justin Grodin
Clinical Conundrums: Managing AFIb and Device Therapies in HF - Case Based Debates (HRS Joint Session)
Moderator(s): Mike Dickinson; Andrea Russo
Debate 1: PRO - AF Ablation Should Be an Early Rhythm Management Strategy for Advanced HF  Speaker: Douglas Packer
Debate 1: CON - AF Ablation Should Be an Early Rhythm Management Strategy for Advanced HF  Speaker: Andrea Russo
Debate 2 : PRO - Patients W/recovered Ejection Fraction Should Undergo Routine Defribillator Generator Change or
Replacement to Prevent Sudden Cardiac Death Risk
Speaker: Lynne Warner Stevenson
Debate 2: CON - Patients W/recovered Ejection Fraction Should Undergo Routine Defribillator Generator Change or
Replacement to Prevent Sudden Cardiac Death Risk
Speaker: Wayne Levy
Debate 3: PRO - Imaging-based Device Optimization Should Be Routinely Performed Following Implantation of Cardiac
Resynchronization Therapy
Speaker: Wilfried Mullens
Debate 3 : CON - Imaging-based Device Optimization Should Be Routinely Performed Following Implantation of Cardiac
Resynchronization Therapy
Speaker: John J. Rickard
Ten Simple Tips for Treating Patients with Diabetes and HF (ADA Joint Session)
Moderator(s): Kirkwood Adams; Anita Deswal
Diabetes and Cardiovascular Risk: Focus on HF  Speaker: David Aguilar
SGLT2 Inhibitors and GLP1 Receptor Agonists in Diabetes and HF: Mechanisms to Clinical Trials  Speaker: Javed Butler
Glucose-lowering Agents to Improve Cardiorespiratory Fitness in HF  Speaker: Salvatore Carbone
Renal Considerations in Treatment of Diabetes with HF  Speaker: Akshay Desai
The Endocrinology Perspective: Management of Diabetes in Patients W/hf- what Goals, What Meds, and by Whom? Speaker: Christina Mitchell
Ten Simple Tips: How to Best Treat Volume Overload in HF: From Medications to Machines
Moderator(s): Jeffrey Testani; Steven Hollenberg
Creative Strategies for Teaching Patients How to Adjust Diruretics  Speaker: Audry Kleet
Treating Volume Overload with Good Ol' Diuretics: What's Works Best?  Speaker: G. Michael Felker
Augmenting Decongestion: When to Use IV Vasodilators and Inotropic Support  Speaker: Ian Hollis
Rise of the Machines: Renal Replacement & Device Therapies to Remove Fluid in Patients W/volume Overload Speaker: Bradley Bart
Therapeutic Innovations to Decongest Patients Hospitalized for Volume Overload  Speaker: Marat Fudim
Ten Simple Tips: Managing Patients Across the Spectrum of Pulmonary Hypertension (Joint Session PHA)
Moderator(s): Jeremy Mazurek; Marc Simon
The Approach to the Patient w/Pulmonary Arterial Hypertension: Case Presentation  Case Presenter: Sophia Airhart
The Approach to the Patient w/Pulmonary Arterial Hypertension: Discussant  Speaker: Anjali Vaidya
The Approach to the Patient w/Pulmonary Hypertension and Sickle Cell Disease: Case Presentation  Case Presenter: Sriram Rao
The Approach to the Patient with Pulmonary Hypertension and Sickle Cell Disease: Case Discussant  Speaker: Marc Simon
The Approach to the Patient w/Complex Mitral Valve Disease and Severe Pulmonary Vascular
Disease: Case Presentation
Case Presenter: Mitchell Psotka
The Approach to the Patient w/Complex Mitral Valve Disease and Severe Pulmonary Vascular
Disease: Case - Discussant
Case Discussant: Mardi Gomberg-Maitland
The Approach to the Patient w/Sleep Apnea and Pulmonary Hypertension: Case Presentation  Case Presenter: Ashrith Guha
The Approach to the Patient w/Sleep Apnea and Pulmonary Hypertension: Discussant  Case Discussant: Susan Joseph
The Approach to the Patient w/Chronic Thromboembolic Pulmonary Hypertension: Case Presentation  Case Presenter: Jeremy Mazurek
The Approach to the Patient w/Chronic Thromboembolic Pulmonary Hypertension: Discussant  Case Discussant: Paul Forfia
 
Accreditation Statement

Physicians


 

The Heart Failure Society of America (HFSA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

HFSA designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

 

Successful completion of this CME activity, which includes participation in the evaluation component and post-test with 75% passing score, enables the participant to earn up to 14.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Faculty and Accreditor Disclosures
Akshay Desai, MD – Brigham and Women's Hospital Research Grant: Astrazeneca, Alnylam, Novartis; Consultant-Advisory Board: Abbott, Astrazeneca, Alnylam, Boehringer Ingelheim, Boston Scientific, Biofourmis, DalCor, Relypsa, Regeneron, Novar-tis
Amil Shah, MD – Brigham and Women's Hospital Research Grant: Novartis; Consultant-Advisory Board: Philips Ultrasound, Bellerophon Therapeutics
Andrea Russo, MD – Cooper University Health Center --  Camden Research Grant: Boehringer Ingelheim, Boston Scientific; Consultant-Advisory Board: Boston Scientific Steering Committee (no honoraria); Apple Res. Steering Committee (no  honoraria)
Arthur Garan, MD – Columbia University Consultant-Advisory Board: Abiomed
Arvind Bhimaraj, MD – Houston Methodist Hospital Consultant-Advisory Board: Abiomed; Abbott
Ashrith Guha, MD – Houston Methodist Hospital Speaker-Honoraria: Bayer Inc., Johnson & Johnson
Daniel Judge, MD – Medical Unviersity of South Carolina -- Charleston Consultant-Advisory Board: Pfizer, 4DMT, Blade Therapeutics
Douglas Packer, MD – Mayo Clinic Research Grant: Abbott, Biosense, Webster, boston Scientific, CardioFocus, CardioIn-sight/Medtronic, Medtronic, St. Jude Medical, Thermedical; Consultant-Advisory Board: Abbott, Biosense Webster, Boston Scientific, Biotronik, CardioFocus, Johnson & Johnson, Medtronic, St. Jude Medical, Thermedical
Edward Soltesz, MD – Cleveland Clinic Honoraria-Speaker: Abbott, Abiomed; Ownership Interest: Jace Medical; Consultant-Advisory Board: Atricure; 
Ileana Pina, MD, MPH – Wayne State University Consultant-Advisory Board:  Relypsa, FDA, CDRH
Orly Vardeny, PharmD – University of Minnesota Medical School Research Grant: Astrazeneca; Consultant-Advisory Board: Novartis
James Januzzi, MD – Massachusetts General Hospital Research Grant: Roche, Abbott, Prevencio, Siemens; Consultant-Advisory Board: : Roche, Abbott, Prevencio, Siemens
James Udelson, MD – Tufts New England Medical Center – Research Grant: Pfizer, Cyclerion, Bayer, LivaNova; Consultant-Advisory Board: Cyclerion, Bayer, Lan-theus, LivaNova, Cardurion
Javed Butler, MD, MPH – University of Mississippi Research Grant: NIH, European Union, PCORI; Consultant-Advisory Board: Amgen, Array, Astra-zeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, CVRx, G3 Pharmaceutical, Innolife, Janssen, Luitpold, Medtronic, Merck, Novartis, Relypsa, Stealth Peptide, SC Pharma, Vifor
Jennifer Thibodeau, MD – UT Southwestern Medical Center Research Grant: Novartis 
Jeremy Mazurek, MD – University of Pennsylvania – Philadelphia Research Grant: United Therapeutics, Actelion Pharmaceuticals, Tenax, Corvia, Complexa; Consultant-Advisory Board: United Therapeutics
Jo Ellen Rodgers, PharmD – University of North Carolina Research Grant: Novartis
John J. Rickard, MD, MBA – Cleveland Clinic Research Grant: Abbott; Speaker-Honoraria: Abbott; Consultant-Advisory Board: Medtronic
Justin Grodin, MD, MPH – UT Southwestern Consultant-Advisory Board: Pfizer
Kavita Sharma, MD – John’s Hopkins University -- Baltimore Speaker-Honoraria: Novartis; Consultant-Advisory Board: Novartis
Kirkwood Adams, MD – The University of North Carolina at Chapel Hill Research Grant: Otsuka, Roche Diagnostics, BMS, Amgen, Boehringer Ingelheim, Merk, Novartis; Consultant-Advisory Board: Relypsa, Cytokinetics, Amgen, Novartis
Marat Fudim, MD – Duke University Consultant-Advisory Board: Axon Therapies, Cordidea, Galvani
Mardi Gomberg-Maitland, MD – George Washington University Consultant-Advisory Board: Janssen/Actelion, Reata, Complexa, Acceleron, United Therapeutics
Mathew Maurer, MD – Research Grant: Pfizer, Eidos; Consultant-Advisory Board: Pfizer, Alnylam, Eidos, Akcea
Mazen Hanna, MD – Cleveland Clinic Consultant-Advisory Board: Pfizer, Akcea, Alnylam, Eidos
G. Michael Felker, MD – Duke University Research Grant: NHLBI, American Heart Association, Amgen, Merck, Cytokinetics, Roche; Consult-ant-Advisory Board: Amgen, Roche, Novartis, Bristol Meyers Squibb, Medtronic, Cardionormic
Michele Hamilton, MD – Cedars Sinai, Beverly Hills Consultant-Advisory Board: Abbott
Omar F. Abou Ezzeddine, MD – Mayo Clinic Research Grant: Pfizer, Inc.
Sami Khella, MD – Penn Medicine Research Grant: Lonis; Consultant-Advisory Board: Alnylam, Lonis, Pfizer
J. Thomas Heywood, MD – Scripps, La Jolla Research Grant: Abbott, Impedimed, VitalMetrics; Speaker-Honoraria: Abbott, Medtronic, Novartis, Actelion, Boehringer-Ingelheim; Consultant-Advisory Board: Medtronic, Impedimed, VitalMetrics, Boston Scientific
Wayne Levy, MD – University of Washington Research Grant: NIH, Novartis; Ownership Interest: Amarin; Consultant-Advisory Board: Medtron-ic, CardioMems/St. Jude Medical/Abbott/Bairn, Evalve, Cardiac Dimensions, Impulse Dynamics, Respircardia, EBR Systems, Inc.
Wayne Miller, MD – Mayo Clinic Research Grant: Daxor Corp, Feldschuh Foundation for Clinical Research
Summary
Availability: Retired
Cost: Member: $145.00
Non-Member: $225.00
Credit Offered:
No Credit Offered
Contains: 10 Courses
Recommended
Powered by Oasis.